Barclays
SGEN

Barclays’s Seagen Inc. Common Stock SGEN Stock Holding History

Barclays’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,500
Closed -$304K – 5240
2023
Q1 		$304K Buy
+1,500
New +$241K ﹤0.01% 3568
2020
Q2 		– Sell
-14,000
Closed -$1.61M – 6405
2020
Q1 		$1.61M Sell
14,000
-3,700
-21% -$410K ﹤0.01% 2482
2019
Q4 		$2.02M Buy
17,700
+9,300
+111% +$986K ﹤0.01% 2986
2019
Q3 		$717K Sell
8,400
-2,300
-21% -$169K ﹤0.01% 3948
2019
Q2 		$741K Buy
10,700
+5,700
+114% +$399K ﹤0.01% 3984
2019
Q1 		$366K Buy
5,000
+1,500
+43% +$107K ﹤0.01% 4360
2018
Q4 		$198K Sell
3,500
-30,700
-90% -$1.93M ﹤0.01% 4583
2018
Q3 		$2.64M Buy
34,200
+27,800
+434% +$2.05M ﹤0.01% 2548
2018
Q2 		$425K Sell
6,400
-2,800
-30% -$160K ﹤0.01% 4106
2018
Q1 		$481K Sell
9,200
-14,600
-61% -$796K ﹤0.01% 4017
2017
Q4 		$1.27M Buy
23,800
+10,600
+80% +$619K ﹤0.01% 2863
2017
Q3 		$718K Sell
13,200
-1,300
-9% -$66.6K ﹤0.01% 3288
2017
Q2 		$750K Buy
14,500
+10,500
+263% +$667K ﹤0.01% 3137
2017
Q1 		$252K Sell
4,000
-500
-11% -$31.2K ﹤0.01% 4084
2016
Q4 		$237K Buy
4,500
+3,600
+400% +$216K ﹤0.01% 4079
2016
Q3 		$49K Sell
900
-13,900
-94% -$659K ﹤0.01% 4991
2016
Q2 		$598K Buy
14,800
+13,700
+1,245% +$521K ﹤0.01% 3054
2016
Q1 		$39K Sell
1,100
-6,900
-86% -$232K ﹤0.01% 4919
2015
Q4 		$352K Sell
8,000
-2,400
-23% -$99.9K ﹤0.01% 3475
2015
Q3 		$395K Sell
10,400
-48,600
-82% -$2.19M ﹤0.01% 3559
2015
Q2 		$2.83M Sell
59,000
-247,100
-81% -$10.2M ﹤0.01% 1936
2015
Q1 		$10.7M Buy
306,100
+283,100
+1,231% +$9.66M 0.01% 1037
2014
Q4 		$736K Sell
23,000
-8,300
-27% -$289K ﹤0.01% 3476
2014
Q3 		$1.16M Buy
31,300
+1,300
+4% +$51.1K ﹤0.01% 3192
2014
Q2 		$1.14M Sell
30,000
-365,100
-92% -$13.8M ﹤0.01% 3205
2014
Q1 		$17.8M Buy
395,100
+325,400
+467% +$15.6M 0.02% 765
2013
Q4 		$2.72M Sell
69,700
-108,300
-61% -$4.42M ﹤0.01% 2361
2013
Q3 		$7.65M Sell
178,000
-331,900
-65% -$13.8M 0.01% 1355
2013
Q2 		$16M Buy
+509,900
New +$17.8M 0.02% 766

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Barclays's SGEN Position: Q4 2023 in Review

Barclays sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,779,070 shares — an estimated $377M sold.

Barclays first reported a position in SGEN in Q2 2013 and held it in 37 quarters. The position peaked at $398M in Q2 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Barclays reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 1,779,070 Seagen Inc. Common Stock shares in Q4 2023, an estimated $377M.
  • Barclays first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 37 quarters.
  • Barclays's Seagen Inc. Common Stock position peaked at $398M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.